Sampling intestinal content with a sequestering capsule. A noninvasive technique for determining bile acid kinetics in man

N. E. Hoffman, Nicholas F La Russo, A. F. Hofmann

Research output: Contribution to journalArticle

Abstract

A noninvasive technique for determining bile acid kinetics by isotope dilution in man features the intravenous injection of a radiolabeled bile acid, together with daily oral administration, for several days, of capsules of dialysis membrane containing cholestyramine and colored beads for dating. The cholestyramine traps conjugated bile acids during transit of the small intestine. Capsules are recovered from stool by sieving, sequestered bile acid is eluted, conjugated bile acids are isolated chromatographically, and their specific activity is determined. The precision and validity of this sequestering capsule technique were assessed by comparing the specific activity decay curve of chenodeoxycholyl conjugates obtained from capsule samples with that obtained from duodenal samples in seven healthy volunteers in whom the bile acid pool had been labeled with [14C]chenodeoxycholic acid. Estimates of pool size by the two methods correlated well (r = 0.98), as did the daily fractional turnover rate (r = 0.96). The mean (±SD) percentage differences for the kinetic parameters of pool size (8.3 ± 13.6), fractional turnover rate (-15.2 ± 11.5), and synthesis rate (-4.3 ± 11.4) were fairly small, indicating that the noninvasive method has validity. However, agreement between simultaneously administered capsules was only fair, especially when the amount of bile acid trapped was small, suggesting that the precision of the capsule technique may be less than that of the conventional duodenal sampling technique; the latter probably obtains a more valid sample of the bile acid pool.

Original languageEnglish (US)
Pages (from-to)171-175
Number of pages5
JournalMayo Clinic Proceedings
Volume51
Issue number3
StatePublished - 1976

Fingerprint

Gastrointestinal Contents
Bile Acids and Salts
Capsules
Cholestyramine Resin
Chenodeoxycholic Acid
Intravenous Injections
Isotopes
Small Intestine
Oral Administration
Dialysis
Healthy Volunteers
Membranes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sampling intestinal content with a sequestering capsule. A noninvasive technique for determining bile acid kinetics in man. / Hoffman, N. E.; La Russo, Nicholas F; Hofmann, A. F.

In: Mayo Clinic Proceedings, Vol. 51, No. 3, 1976, p. 171-175.

Research output: Contribution to journalArticle

@article{a4eb9455eeeb4e8e9cbd4468ae7e7ce3,
title = "Sampling intestinal content with a sequestering capsule. A noninvasive technique for determining bile acid kinetics in man",
abstract = "A noninvasive technique for determining bile acid kinetics by isotope dilution in man features the intravenous injection of a radiolabeled bile acid, together with daily oral administration, for several days, of capsules of dialysis membrane containing cholestyramine and colored beads for dating. The cholestyramine traps conjugated bile acids during transit of the small intestine. Capsules are recovered from stool by sieving, sequestered bile acid is eluted, conjugated bile acids are isolated chromatographically, and their specific activity is determined. The precision and validity of this sequestering capsule technique were assessed by comparing the specific activity decay curve of chenodeoxycholyl conjugates obtained from capsule samples with that obtained from duodenal samples in seven healthy volunteers in whom the bile acid pool had been labeled with [14C]chenodeoxycholic acid. Estimates of pool size by the two methods correlated well (r = 0.98), as did the daily fractional turnover rate (r = 0.96). The mean (±SD) percentage differences for the kinetic parameters of pool size (8.3 ± 13.6), fractional turnover rate (-15.2 ± 11.5), and synthesis rate (-4.3 ± 11.4) were fairly small, indicating that the noninvasive method has validity. However, agreement between simultaneously administered capsules was only fair, especially when the amount of bile acid trapped was small, suggesting that the precision of the capsule technique may be less than that of the conventional duodenal sampling technique; the latter probably obtains a more valid sample of the bile acid pool.",
author = "Hoffman, {N. E.} and {La Russo}, {Nicholas F} and Hofmann, {A. F.}",
year = "1976",
language = "English (US)",
volume = "51",
pages = "171--175",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Sampling intestinal content with a sequestering capsule. A noninvasive technique for determining bile acid kinetics in man

AU - Hoffman, N. E.

AU - La Russo, Nicholas F

AU - Hofmann, A. F.

PY - 1976

Y1 - 1976

N2 - A noninvasive technique for determining bile acid kinetics by isotope dilution in man features the intravenous injection of a radiolabeled bile acid, together with daily oral administration, for several days, of capsules of dialysis membrane containing cholestyramine and colored beads for dating. The cholestyramine traps conjugated bile acids during transit of the small intestine. Capsules are recovered from stool by sieving, sequestered bile acid is eluted, conjugated bile acids are isolated chromatographically, and their specific activity is determined. The precision and validity of this sequestering capsule technique were assessed by comparing the specific activity decay curve of chenodeoxycholyl conjugates obtained from capsule samples with that obtained from duodenal samples in seven healthy volunteers in whom the bile acid pool had been labeled with [14C]chenodeoxycholic acid. Estimates of pool size by the two methods correlated well (r = 0.98), as did the daily fractional turnover rate (r = 0.96). The mean (±SD) percentage differences for the kinetic parameters of pool size (8.3 ± 13.6), fractional turnover rate (-15.2 ± 11.5), and synthesis rate (-4.3 ± 11.4) were fairly small, indicating that the noninvasive method has validity. However, agreement between simultaneously administered capsules was only fair, especially when the amount of bile acid trapped was small, suggesting that the precision of the capsule technique may be less than that of the conventional duodenal sampling technique; the latter probably obtains a more valid sample of the bile acid pool.

AB - A noninvasive technique for determining bile acid kinetics by isotope dilution in man features the intravenous injection of a radiolabeled bile acid, together with daily oral administration, for several days, of capsules of dialysis membrane containing cholestyramine and colored beads for dating. The cholestyramine traps conjugated bile acids during transit of the small intestine. Capsules are recovered from stool by sieving, sequestered bile acid is eluted, conjugated bile acids are isolated chromatographically, and their specific activity is determined. The precision and validity of this sequestering capsule technique were assessed by comparing the specific activity decay curve of chenodeoxycholyl conjugates obtained from capsule samples with that obtained from duodenal samples in seven healthy volunteers in whom the bile acid pool had been labeled with [14C]chenodeoxycholic acid. Estimates of pool size by the two methods correlated well (r = 0.98), as did the daily fractional turnover rate (r = 0.96). The mean (±SD) percentage differences for the kinetic parameters of pool size (8.3 ± 13.6), fractional turnover rate (-15.2 ± 11.5), and synthesis rate (-4.3 ± 11.4) were fairly small, indicating that the noninvasive method has validity. However, agreement between simultaneously administered capsules was only fair, especially when the amount of bile acid trapped was small, suggesting that the precision of the capsule technique may be less than that of the conventional duodenal sampling technique; the latter probably obtains a more valid sample of the bile acid pool.

UR - http://www.scopus.com/inward/record.url?scp=0017282451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017282451&partnerID=8YFLogxK

M3 - Article

C2 - 768646

AN - SCOPUS:0017282451

VL - 51

SP - 171

EP - 175

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -